早期非小细胞肺癌不同放疗技术的剂量学差异分析

doi:10.3760/cma.j.issn.1004-4221.2017.01.014

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (900 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

目的比较早期周围型NSCLC不同放疗技术的剂量学差异,探讨合适治疗手段。方法对2014—2015年间收治的5例病理确诊的T₁、T₂期周围型NSCLC行4DCT定位,勾画靶区和OAR。靶区包括GTV、ITV和PTV,ITV在最大密度投影图像上勾画,PTV=ITV+5 mm;OAR主要包括心脏、肺、食管、脊髓等。用Monaco 5.0 TPS进行计划设计,设计3种计划:(1)3DCRT:11个野,在患侧肺布野,射野形状与PTV适形,PTV外放0.2 cm边界;(2) SW-IMRT:9个野,布野方式同3DCRT;(3) VMAT:机架绕患侧肺旋转180°。计划评估标准参照RTOG0618。配对t检验差异。结果 3种计划PTV的D_2%、D_5%、D_98%、D_95%、D_50%、HI、CI和机器跳数中,SW-IMRT计划HI较3DCRT好(1.03∶1.24,P=0.017);3DCRT计划机器跳数平均值较VMAT减少24.5%(P=0.022);OAR剂量学参数中3DCRT计划的V₃₀、V₄₀较SW-IMRT和VMAT的分别降低29.4%、28.4%和56.7%、59.7%(P=0.003、0.006和P=0.041、0.019)。结论早期NSCLC的放疗技术中3DCRT可能是较为合适的技术。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	郭跃信
	王海洋
	刘乐乐
	刘帅蓬

关键词 ：癌,非小细胞肺/放射疗法, 放射疗法,三维适形, 放射疗法,动态滑窗调强, 放射疗法,动态旋转调强

Abstract：

Objective To explore the dosimetric difference between different radiotherapytechnologies in the treatment of early peripheral stage non-small-cell lung cancer (NSCLC). Methods
Four-dimensional computed tomography scans and delineation of target volumes and organs at risk (OARs) were performed in 5 patients pathologically diagnosed with stage T₁/T₂ peripheral NSCLC who were admitted from 2014 to 2015. Target volumes contained gross tumor volume (GTV), internal target volume (ITV), and planning target volume (PTV). ITV was contoured on the maximum intensity projection images. PTV was defined as ITV plus a 5 mm margin. OARs contained the heart, lung, esophagus, and spinal cord. The Monaco 5.0 treatment planning system was used to design three plans. The three-dimensional conformal radiotherapy (3DCRT) plan had 11 fields in the diseased lung covering the PTV plus a 0.2 cm margin. The sliding window intensity-modulated radiotherapy (SW-IMRT) plan had 9 fields in the same areas as the 3DCRT plan. The volumetric modulated arc therapy (VMAT) plan had the gantry rotating 180° around the diseased lung. The evaluation criteria referred to the RTOG 0618 trial. Comparison was made by paired t test. Results The SW-IMRT plan had a significantly better homogeneity index than the 3DCRT plan (1.03 vs. 1.24,P=0.017). Compared with the VMAT plan, the mean monitor units in the 3DCRT plan was significantly reduced by 24.5%(P=0.022). The V₃₀ and V₄₀ of the 3DCRT plan were significantly reduced by 29.4% and 28.4%, respectively, compared with the SW-IMRT plan (P=0.003,0.006) and 56.7% and 59.7%, respectively, compared with the VMAT plan (P=0.041,0.019). Conclusions 3DCRT may be an appropriate radiotherapy method for early stage NSCLC.

Key words： Carcinoma,non-small lung/radiotherapy Radiotherapy,three-dimensional conform Radiotherapy,sliding window-intensity modulated Radiotherapy,volume modulated

收稿日期: 2015-10-08

基金资助:

河南省医学科技攻关项目(201303043)

引用本文:

郭跃信,王海洋,刘乐乐等. 早期非小细胞肺癌不同放疗技术的剂量学差异分析[J]. 中华放射肿瘤学杂志, 2017, 26(1): 62-65.

Guo　Yuexin,Wang Haiyang,Liu Lele et al. Analysis of the dosimetry differences between peripheral early stage non-small cell lung cancer (NSCLC) treated with SBRT technique[J]. Chinese Journal of Radiation Oncology, 2017, 26(1): 62-65.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2017.01.014 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2017/V26/I1/62

[1] Louie AV,Rodrigues G,Hannouf M,et al. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer:a Markov model-based decision analysis[J].Int J Radiat Oncol Biol Phys,2011,81(4):964-973.DOI:10.1016/j.ijrobp.2010.06.040.
[2] Jones AO,Das IJ.Comparison of inhomogeneity correction algorithms in small photon fields[J].Med Phys,2005,32(3):766-776.DOI:10.1118/1.1861154.
[3] Bortfeld T,Jokivarsi K,Goitein M,et al. Effects of intra-fraction motion on IMRT dose delivery:statistical analysis and simulation[J].Phys Med Biol,2002,47(13):2203-2220.DOI:10.1088/0031-9155/47/13/302.
[4] Ginsberg RJ,Rubinstein LV.Randomized trial of lobectomy versus limited resection for T₁N₀ non-small cell lung cancer. Lung Cancer Study Group[J].Ann Thorac Surg,1995,60(3):615-622.DOI:10.1016/0003-4975(95)00537-U.
[5] Mountain CF.A new international staging system for lung cancer[J].Chest,1986,89(4S):225S-233S.DOI:10.1378/chest.89.4_Supplement.225S.
[6] Naruke T,Goya T,Tsuchiya R,et al. Prognosis and survival in resected lung carcinoma based on the new international staging system[J].J Thorac Cardiovasc Surg,1988,96(3):440-447.
[7] Grills IS,Mangona VS,Welsh R,et alOutcomes after stereotactic lung radiotherapy or wedge resection for stage Ⅰ non-small-cell lung cancer[J].J Clin Oncol,2010,28(6):928-935.DOI:10.1200/JCO.2009.25.0928.
[8] Jiwnani S,Karimundackal G,Pramesh CS.Stereotactic radiotherapy versus sublobar lung resection in medically unfit patients with early-stage non-small-cell lung cancer[J].J Clin Oncol,2010,28(29):e569-e570.DOI:10.1200/JCO.2010.29.4108.
[9] Matuszak MM,Yan D,Grills I,et al. Clinical applications of volumetric modulated arc therapy[J].Int J Radiat Oncol Biol Phys,2010,77(2):608-616.DOI:10.1016/j.ijrobp.2009.08.032.
[10] Diot Q,Kavanagh B,Timmerman R,et al. Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy[J].Med Phys,2012,39(1):237-245.DOI:10.1118/1.3668059.
[11] Wang SL,Liao ZX,Wei X,et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)[J].Int J Radiat Oncol Biol Phys,2006,66(5):1399-1407.DOI:10.1016/j.ijrobp.2006.07.1337.